At the thyroidectomy, among 14 patients with the BRAF V600E variant according to residual FNA analysis, 13 were diagnosed with PTC and 1 was diagnosed with ATC; while among 34 patients without the BRAF V600E variant, 24 were diagnosed with PTC, 1 was diagnosed with metastatic renal cell carcinoma invasion to the thyroid, 1 was diagnosed with squamous cell carcinoma invasion to the thyroid, and 8 were diagnosed with benign tumors (Table 2). This evidence concerns the gene BRAF and squamous cell carcinoma.